Highlander Capital Management, LLC Sarepta Therapeutics, Inc. Transaction History

Highlander Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $33,663 - $45,585	-300 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $32,001 - $45,504	300 New	300 $36,000
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $29,195 - $44,628	-300 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$115.31 - $161.51 $34,593 - $48,453	300 New	300 $48,000
Q4 2017 Feb 13, 2018	SELL	$47.64 - $56.75 $23,820 - $28,375	-500 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$35.73 - $47.15 $17,865 - $23,575	500	500 $23,000

532

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.15B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Highlander Capital Management, LLC with notifications on news.